Sugi Predict

Sugi Predict / Compounds / SCHEMBL30608587

SCHEMBL30608587

SCHEMBL30608587

CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)O)C(C)C

nearest known ligand 0.46

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ NAA50 Q9GZZ1 1/20 0.46
▸ CAPN1 P07384 2/20 0.46
▸ CRHR1 P34998 1/20 0.42
▸ CRHR2 Q13324 1/20 0.42
▸ NTSR1 P30989 1/20 0.41
▸ CTSD P07339 1/20 0.41
▸ BACE1 P56817 1/20 0.41
▸ CALCR P30988 3/20 0.41
▸ PLK1 P53350 1/20 0.41
▸ APLNR P35414 2/20 0.40
▸ GLP1R P43220 6/20 0.40
▸ GCGR P47871 3/20 0.40
▸ GRPR P30550 1/20 0.40
▸ GIPR P48546 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30608578 0.96 NAA50 (0.49) NAA50CAPN1CRHR1CRHR2NTSR1
SCHEMBL30608616 0.95 NAA50 (0.48) NAA50CAPN1CRHR1CRHR2NTSR1
SCHEMBL30608591 0.95 NAA50 (0.46) NAA50CAPN1CRHR1CRHR2NTSR1
SCHEMBL30608630 0.95 NAA50 (0.46) NAA50CAPN1CRHR1CRHR2NTSR1
SCHEMBL30608582 0.95 NAA50 (0.48) NAA50CAPN1CRHR1CRHR2NTSR1
SCHEMBL30608619 0.94 NAA50 (0.49) NAA50CAPN1CRHR1CRHR2NTSR1
SCHEMBL30608589 0.93 CAPN1 (0.50) NAA50CAPN1CRHR1CRHR2NTSR1
SCHEMBL30608576 0.93 CAPN1 (0.49) NAA50CAPN1CRHR1CRHR2NTSR1
SCHEMBL30608598 0.92 NAA50 (0.49) NAA50CAPN1CRHR1CRHR2NTSR1
SCHEMBL30608609 0.92 NAA50 (0.49) NAA50CAPN1CRHR1CRHR2NTSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4646232-A1 VARIANT LIGAND CONJUGATES FOR PAYLOAD DELIVERY Université de Genève (CH) 2025-11-12 — — EP claimed
WO-2024146707-A1 VARIANT LIGAND CONJUGATES FOR PAYLOAD DELIVERY UNIVERSITÉ DE GENÈVE (CH) 2024-07-11 — — WO claimed
EP-4646232-A1 VARIANT LIGAND CONJUGATES FOR PAYLOAD DELIVERY Université de Genève (CH) 2025-11-12 — — EP disclosed
US-20250090637-A1 METHODS OF INHIBITING CEREBRAL INFLAMMATION UNIVERSITÉ DE GENÈVE (CH) 2025-03-20 — — US disclosed
CN-112469429-B Use of CCR5 inhibitors in cancer treatment 奥立安生物技术瑞士有限责任公司 2025-02-14 — — CN disclosed
CN-112469430-B Method for inhibiting cerebral inflammation 日内瓦大学 2024-12-24 — — CN disclosed
WO-2024146707-A1 VARIANT LIGAND CONJUGATES FOR PAYLOAD DELIVERY UNIVERSITÉ DE GENÈVE (CH) 2024-07-11 — — WO disclosed
EP-3813870-B1 CCR5 INHIBITOR FOR USE IN TREATING CANCER ORION Biotechnology Switzerland Sarl (CH) 2023-11-15 — — EP disclosed
EP-3813869-B1 CCR5 INHIBITOR FOR USE IN TREATING A NEUROINFLAMMATORY DISORDER THAT INVOLVES CEREBRAL INFLAMMATION UNIV GENEVE (CH) 2023-10-18 — — EP disclosed
Send feedback